We are live on ! Find out more
CNSY

Cerenome, Inc. Common Stock

4 hedge funds and large institutions have $7.5M invested in Cerenome, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 54 (-1)

33% less capital invested

Capital invested by funds: $11.1M → $7.5M (-$3.62M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$76K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
76
Renaissance Technologies
New York
-$321K
SG Americas Securities
77
SG Americas Securities
New York
-$9K
TRCT
78
Tower Research Capital (TRC)
New York
-$25K
T. Rowe Price Associates
79
T. Rowe Price Associates
Maryland
-$45K

CNSY Hedge Fund Activity: Q4 2014 in Review

4 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Cerenome, Inc. Common Stock (CNSY) for Q4 2014, worth a combined $7.5M — down 33% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CNSY and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Goldman Capital Management, exiting entirely with an estimated $1.36M sold.

  • 4 institutional investors held Cerenome, Inc. Common Stock (CNSY) as of Q4 2014, down from 5 in Q3 2014.
  • Funds reported $7.5M of Cerenome, Inc. Common Stock stock for Q4 2014, down 33% quarter-over-quarter.
  • 0 funds opened new Cerenome, Inc. Common Stock positions in Q4 2014 and 1 closed out, a net change of -1 holder.
  • The largest Cerenome, Inc. Common Stock seller in Q4 2014 was Goldman Capital Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q4 2014.